EN
An update from Daniel
We’re confident our clinically driven AI and medical knowledge leads the industry and we welcome scientific scrutiny.
Negocios & industria
El aspecto empresarial de la tecnología de la salud: nuestras colaboraciones y alianzas, comentarios de expertos y campañas galardonadas.
ENPutting AI to work: How can we overcome barriers to AI adoption in healthcare?
How can we speed up the adoption of AI solutions? Let’s look at some of the challenges we face and how we can overcome them.
ENThe People Behind the Products: Dr. Claire Novorol and Ada Health
From the beginning, we’ve been combining global medical knowledge with a unique AI approach to improve health outcomes.
ENGetting medics back to hospital faster with smooth COVID-19 tests
“In case I need to be tested again, which can happen at any time, it’s a relief to know that I can get my test results this fast.”
Better together: Collaborating with healthcare organizations around the world in the fight against COVID-19
I look forward to a more collaborative future for health and tech, working together to improve access to healthcare.
Helping rare starts with finding rare
We chat to our Rare Disease Lead, Vanessa Lemarié, about challenges in rare disease and how AI could help reduce its burden.
ENNine experts on the trends that changed healthtech in the last decade, and the innovations to expect by 2030
Dr. Claire Novorol and industry experts reflect on the past decade and predict the next healthcare trends in the 2020s.
Helping health systems catch up with innovation
Our #meetAda event focused on what digital health innovators can do to help health systems start taking digital health seriously.
Putting the ‘med’ in medtech: three tips for how clinicians can succeed in digital health
The only way to build effective products and services for healthcare is to make clinicians part of the process.
Diversity in healthtech: why securing funding is harder for female founders
Rock Health’s analysis found that just one in seven health tech startups that received investment in 2018 had a female CEO.
It’s time for a better dialogue between regulators and healthtech pioneers
The current regulatory landscape is complex and not set up to respond rapidly to the proliferation of new healthtech products...
